Independent prognostic value of the 67-kd laminin receptor in human prostate cancer

Waltregny, David; de Leval, Laurence; Menard, Sylvie; de Leval, Jean; Castronovo, Vincenzo

doi:10.1093/jnci/89.16.1224

No full text

Article (Scientific journals)

Independent prognostic value of the 67-kd laminin receptor in human prostate cancer

Waltregny, David; de Leval, Laurence; Menard, Sylvie et al.

1997 • In Journal of the National Cancer Institute, 89 (16), p. 1224-7

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/4719

DOI
10.1093/jnci/89.16.1224

PubMed
9274918

Files (0)Send to Details Statistics Bibliography Similar publications

Files

Full Text

No document available.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Adenocarcinoma/immunology/secondary/surgery; Cohort Studies; Disease-Free Survival; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Odds Ratio; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen/metabolism; Prostatectomy; Prostatic Neoplasms/immunology/pathology/surgery; Receptors, Laminin/metabolism; Risk; Tumor Markers, Biological/metabolism

Disciplines :

Urology & nephrology

Author, co-author :

Waltregny, David ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Labo de recherche sur les métastases - Département des sciences biomédicales et précliniques

de Leval, Laurence ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique

Menard, Sylvie

de Leval, Jean ; Université de Liège - ULiège > Département des sciences cliniques > Urologie

Castronovo, Vincenzo ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire - Labo de recherche sur les métastases

Language :

English

Title :

Independent prognostic value of the 67-kd laminin receptor in human prostate cancer

Publication date :

1997

Journal title :

Journal of the National Cancer Institute

ISSN :

0027-8874

eISSN :

1460-2105

Publisher :

Oxford University Press, Cary, United States - North Carolina

Volume :

Issue :

Pages :

1224-7

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 25 January 2009

Statistics

Number of views

36 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Lerner SE, Seay TM, Blute ML, Bergstralh EJ, Barrett D, Zincke H. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. J Urol 1996;155: 821-6.
Oesterling JE, Suman VJ, Zincke H, Bostwick DG. PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors. Urol Clin North Am 1993;20: 687-93.
Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271: 368-74.
Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270: 948-54.
Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 1994;152: 1732-6.
Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, et al. Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 1989;141:1076-83.
Paulson DF, Moul JW, Walther PJ. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J Urol 1990;144:1180-4.
Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock EC, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988;139:766-72.
Walsh PC, Lepor H. The role of radical prostatectomy in the management of prostatic cancer. Cancer 1987;60(3 Suppl):526-37.
(1O) Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR. Laminin - a glycoprotein from basement membranes. J Biol Chem 1979;254:9933-7.
Timpl R, Engel J, Martin GR. Laminin: a multifunctional protein of basement membranes. Trends Biochem 1983;8:207-9.
Kleinman HK, Cannon FB, Laurie GW, Hassell JR, Aumailley M, Terranova VP, et al. Biological activities of laminin. J Cell Biochem 1985;27:317-25.
Engel J, Odermatt E, Engel A, Madri J, Furthmayr H, Rohde H, et al. Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix. J Mol Biol 1981;150: 97-120.
Terranova VP, Liotta LA, Russo RG, Martin GR. Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res 1982;4:2265-9.
Malinoff HL, McCoy JP Jr, Varani J, Wicha MS. Metastatic potential of murine fibrosarcoma cells is influenced by cell surface laminin. Int J Cancer 1984;33:651-5.
Barsky SH, Rao CN, Williams JE, Liotta LA. Laminin molecular domains which alter metastasis in a murine model. J Clin Invest 1984;74:843-8.
Castronovo V. Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis 1993;13: 1-30.
Rao NC, Barsky SH, Terranova VP, Liotta LA. Isolation of tumor cell laminin receptor. Biochem Biophys Res Commun 1983;111: 804-8.
Kleinman HK, Ogle RC, Cannon FB, Little CD, Sweeney TM, Luckenbill-Edds L. Laminin receptors for neurite formation. Proc Natl Acad Sci U S A 1988;85:1282-6.
Castronovo V, Taraboletti G, Liotta LA, Sobel ME. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. J Natl Cancer Inst 1989;81:781-8.
Wewer UM, Taraboletti G, Sobel ME, Albrechtsen R, Liotta LA. Role of laminin receptor in tumor cell migration. Cancer Res 1987;47:5691-8.
Martignone S, Menard S, Bufalino R, Cascinelli N, Pellegrini R, Tagliabue E, et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 1993;85: 398-402.
Daidone MG, Silvestrini R, D'Errico A, Di Fronzo G, Benini E, Mancini AM, et al. Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer 1991;48:529-32.
Pellegrini R, Martignone S, Tagliabue E, Belotti D, Bufalino R, Cascinelli N, et al. Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas. Breast Cancer Res Treat 1995;35:195-9.
Mafune K, Ravikumar TS, Wong JM, Yow H, Chen LB, Steele GD Jr. Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression. Cancer Res 1990;50:3888-91.
Cioce V, Castronovo V, Shmookler BM, Garbisa S, Grigioni WF, Liotta LA, et al. Increased expression of the laminin receptor in human colon cancer. J Natl Cancer Inst 1991;83:29-36.
Campo E, Monteagudo C, Castronovo V, Claysmith AP, Fernandez PL, Sobel ME. Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization. Am J Pathol 1992;141: 1073-83.
D'Errico A, Garbisa S, Liotta LA, Castroinno V, Stetler-Stevenson WG, Grigioni WF. Augmentation of type IV collagenase. laminin receptor, and ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 1991;4:239-46.
van den Brule FA, Castronovo V, Menard S, Giavazzi R, Marzola M, Belotti D, et al. Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5. Eur J Cancer 1996;32A:1598-602.
Demeter LM, Stoler MH, Sobel ME, Broker TR, Chow LT. Expression of high-affinity laminin receptor mRNA correlates with cell proliferation rather than invasion in human papillomavirus-associated cervical neoplasms. Cancer Res 1992;52:1561-7.
Pellegrini R, Martignone S, Menard S, Colnaghi MI. Laminin receptor expression and function in small-cell lung carcinoma. Int J Cancer 1994;Suppl 8:116-20.
Satoh K, Narumi K, Isemura M, Sakai T, Abe T, Matsushima K, et al. Increased expression of the 67kDa-laminin receptor gene in human small cell lung cancer. Biochem Biophys Res Commun 1992;182:746-52.
Basolo F, Pollina L, Pacini F, Fontanini G, Menard S, Castronovo V, et al. Expression of the 67 KD laminin receptor is an adverse prognostic indicator in human thyroid cancer: immunohistochemical study. Clin Cancer Res 1996;2:1777-80.
Grigioni WF, Garbisa S, D'Errico A, Baccarini P, Stetler-Stevenson WG, Liotta LA, et al. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol 1991;138: 647-54.
Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl 1992;4:129-38.
Mariani-Constantini R, Barbanti P, Colnaghi MI, Menard S, Clemente C, Rilke F. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations. Am J Pathol 1984;115:47-56.
Menard S, Tagliabue E, Canevari S, Fossati G, Colnaghi MI. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res 1983;43: 1295-300.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187.
Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.